Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › SCDs as modifiers of the p53 pathway and methods of use

SCDs as modifiers of the p53 pathway and methods of use

US Patent 8771942 · Granted Jul 8, 2014

Estimated economic value: $8,473,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Checkpoint inhibitor bispecific antibodies2021
Fatty acid synthase inhibitor for use in the treatment of drug resistant cancer2019
Heterocyclic modulators of lipid synthesis and combinations thereof2019
Heterocyclic modulators of lipid synthesis2019
Methods of treating PR-positive, luminal A breast cancer with PI3K inhibitor, pi2018
Heterocyclic modulators of lipid synthesis for use against cancer and viral infe2018
Methods and compositions for modulating estrogen receptor mutants2018
Use of a combination of a MEK inhibitor and an ERK inhibitor for treatment of hy2017
Compounds to fibroblast growth factor receptor-3 (FGFR3) and methods of treatmen2016
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeut2016
Antibodies2016
Methods for diagnosis, prognosis and methods of treatment2015